Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
+3.55M
-
Total reported value, excl. options
-
$470M
-
Value change
-
+$100M
-
Put/Call ratio
-
0.46
-
Number of buys
-
78
-
Number of sells
-
-31
-
Price
-
$25.75
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2019
132 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2019.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
of 48.9M outstanding shares and own 37.32% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.69M shares), VHCP Management III, LLC (1.61M shares), RA CAPITAL MANAGEMENT, LLC (1.34M shares), ALETHEA CAPITAL MANAGEMENT, LLC (1.3M shares), VANGUARD GROUP INC (1.15M shares), VHCP Management II, LLC (893K shares), Ghost Tree Capital, LLC (850K shares), RTW INVESTMENTS, LP (844K shares), Invesco Ltd. (808K shares), and BAKER BROS. ADVISORS LP (772K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.